Article Versions Notes

Tamura R, Morimoto Y, Sato M, Hikichi T, Yoshida K, Toda M. A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma. Vaccines. 2020; 8(3):498. https://doi.org/10.3390/vaccines8030498

Tamura, Ryota, Yukina Morimoto, Mizuto Sato, Tetsuro Hikichi, Kazunari Yoshida, and Masahiro Toda. 2020. "A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma" Vaccines 8, no. 3: 498. https://doi.org/10.3390/vaccines8030498

Tamura, R., Morimoto, Y., Sato, M., Hikichi, T., Yoshida, K., & Toda, M. (2020). A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma. Vaccines, 8(3), 498. https://doi.org/10.3390/vaccines8030498